This Antibody was verified by KnockDown to ensure that the antibody binds to the antigen stated. View Details
PA5-27827 targets CDK4 in IF, IHC (P), and WB applications and shows reactivity with Human and mouse samples.
The PA5-27827 immunogen is recombinant fragment corresponding to a region within amino acids 148 and 303 of Human CDK4.
The protein encoded by this gene is a member of the Ser/Thr protein kinase family. This protein is highly similar to the gene products of S. cerevisiae cdc28 and S. pombe cdc2. It is a catalytic subunit of the protein kinase complex that is important for cell cycle G1 phase progression. The activity of this kinase is restricted to the G1-S phase, which is controlled by the regulatory subunits D-type cyclins and CDK inhibitor p16(INK4a). This kinase was shown to be responsible for the phosphorylation of retinoblastoma gene product (Rb). Mutations in this gene as well as in its related proteins including D-type cyclins, p16(INK4a) and Rb were all found to be associated with tumorigenesis of a variety of cancers. Multiple polyadenylation sites of this gene have been reported.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Cell division protein kinase 4; CMM3; CRK3; cyclin dependent kinase 4; Cyclin-dependent kinase 4; p34
Gene Aliases: CDK4; CMM3; Crk3; PSK-J3